Natural health product · NPN 80115592
Plexus Barrier
No: licence discontinued
The licence holder discontinued the product licence.
Licence status Discontinued; licensed January 18, 2022.
- Natural Product Number (NPN)
- 80115592
- Licence holder
- Plexus Canada Limited Partnership
- Dosage form
- Powder
- Route
- Oral
- Licensing route
- General (non-traditional)
- First licensed
- January 18, 2022
Medicinal ingredients
Per dosage unit, as licensed.
| Ingredient | Amount | Source and potency |
|---|---|---|
| (S)-2,3-Dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-4- benzopyrone | 6.25 mg | Citrus maxima - Fruit |
| Althaea officinalis | 175 mg | Root; 10:1 Dry; equivalent to 1750 mg dried herb |
| N-(2-Hydroxyethyl)hexadecanamide | 10 mg | Palmitoylethanolamide |
| Ulmus rubra | 12.5 mg | Stem bark; 10:1 Dry; equivalent to 125 mg dried herb |
| L-Glutamine | 750 mg | L-Glutamine |
| Glycyrrhiza glabra | 175 mg | Root; 4:1 Dry; equivalent to 700 mg dried herb |
| 2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4-benzopyrone | 6.25 mg | Luteolin |
| Acacia | 2,500 mg | Acacia group - Gum |
What it is licensed for
The licence’s own wording. Directions, doses, cautions and warnings are on the official record and the label.
- Source of fibre (for the maintenance of good health). Helps support digestive system health after periods of physical stress. Used in Herbal Medicine to help relieve inflammatory conditions of the gastrointestinal tract, such as gastritis in adults.
Non-medicinal ingredients
Stevia leaf extract